To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sandoz
Related studies linked through entity extraction aliases.
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
- Status
- WITHDRAWN
- Phase
- PHASE3
Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1